Results 191 to 200 of about 86,557 (257)
Microbiota‐targeted therapeutic strategies in hematological disorders. aHSCT: Transplanted immune cells from the donor may attack the recipient's tissues, especially when damage to the intestinal epithelium disrupts the gut microbiota, contributing to GVHD. Maintaining a balanced gut microbiota that supports immune regulation helps reduce GVHD risk and
Alireza Molajafari +3 more
wiley +1 more source
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF. [PDF]
Jiang SY +17 more
europepmc +1 more source
Schematic overview of the human microbiome and major microbiota‐derived metabolites across body sites, highlighting the gut–brain, gut–heart, and gut–kidney axes in host physiology and disease. ABSTRACT Background The human microbiome is a dynamic and diverse community of microorganisms that affects susceptibility to illness and promotes wellness ...
Awadh Alanazi
wiley +1 more source
Rapid food desensitization associated with omalizumab before oral immunotherapy. [PDF]
Giavina-Bianchi B, Giavina-Bianchi P.
europepmc +1 more source
Intelligent design of artificial biocatalyst for biomedical diseases
This review summarizes recent advances in the intelligent design of artificial biocatalysts for biomedical diseases. By leveraging tailored design strategies, including environment‐responsive engineering and rational/artificial intelligence‐aided optimization, these biocatalysts enable precise modulation of pathological microenvironments and targeted ...
Lijie Zhang +3 more
wiley +1 more source
Sex assigned at birth may modify health-related quality of life in children treated with peanut oral immunotherapy. [PDF]
Rosser SA +7 more
europepmc +1 more source
Deep learning‐assisted design of nanozyme for immune regulation
Overview of nanozyme‐based strategies for inflammatory bowel disease therapy, featuring metal‐based and non‐metallic nanozymes classified by structure, alongside multifunctional and engineered probiotic‐based nanozymes classified by function. Abstract Inflammatory bowel disease (IBD), with rising global incidence and disease burden, is a multifactorial
Ke Chen +3 more
wiley +1 more source
The Role of Omalizumab as an Adjunct to Oral Immunotherapy in Pediatric Food Allergy: A Systematic Review. [PDF]
Khidir Mustafa AA +6 more
europepmc +1 more source
[Oral immunotherapy versus parenteral immunotherapy].
A, Romo +4 more
openaire +1 more source

